Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2